Baby Teething Gel (Benzocaine/Lidocaine Topical Oral Analgesic) — child safety profile
Severe riskTopical numbing gels applied to infant gums during teething (typically 4-24 months).
What is this product?
Topical numbing gels applied to infant gums during teething (typically 4-24 months). Active ingredients benzocaine and lidocaine carry FDA black box warnings for methemoglobinemia risk in children under 2. Despite FDA advisories since 2018, many products remain available internationally. Additional concerns include choking risk from numbed swallowing reflex, and preservative/flavoring absorption through highly vascular oral mucosa in infants.
What's in it
Click any compound name for its full safety profile, regulatory consensus, and exposure data.
Reference: Topical Oral Antiseptic Class
Preservative (Methylparaben)
Sweetener (Saccharin)
Vehicle/Solvent (Propylene Glycol)
Who's most at risk
- Infants — Developing organ systems, higher exposure per body weight, immature detoxification systems
- Children — Developing endocrine and neurological systems, higher exposure per body weight
Frequently asked questions
What's in Baby Teething Gel (Benzocaine/Lidocaine Topical Oral Analgesic)?
This product type can contain: Chlorhexidine, Methylparaben, Saccharin, Propylene glycol, among others. Click any compound name above for the full safety profile.
Who should be careful with Baby Teething Gel (Benzocaine/Lidocaine Topical Oral Analgesic)?
Vulnerable populations identified for this product type: infants, children.
Look up Baby Teething Gel (Benzocaine/Lidocaine Topical Oral Analgesic) in the baby app
Search by ingredient, browse by category, or compare to alternatives in the live app.
Open in baby View raw API dataReference data, not professional advice. Aggregates publicly available regulatory and scientific information. Why we built ALETHEIA →